In the Canadian medical devices industry, there were 3 M&A deals announced in Q4 2023, worth a total value of $253m, according to GlobalData’s Deals Database. The $253m acquisition of Opsens by Haemonetics was the industry’s largest disclosed deal. GlobalData’s Medical Devices Industry Mergers and Acquisitions Deals by Top Themes in 2023 report helps understand the pivotal themes steering M&A activity in the industry. Buy the report here.
In value terms, M&A activity in Canada remained flat in Q4 2023 compared with the previous quarter and as compared to Q4 2022. Related deal volume increased by 50% in Q4 2023 versus the previous quarter and was 57% lower than in Q4 2022.
The top-ranked financial advisors supporting these M&A deals in Canada in Q4 2023 were Piper Sandler Companies; Bloom Burton Securities; Goldman Sachs Group with 2, 1, 1 deals respectively.
The top-ranked legal advisorss supporting these M&A deals in Canada Q4 2023 were Blake, Cassels & Graydon; Davies Ward Phillips & Vineberg; DLA Piper International with 1, 1, 1 deals respectively.
See Also:
For further understanding of GlobalData's Medical Devices Industry Mergers And Acquisitions Deals By Top Themes In 2023 – Thematic Intelligence, buy the report here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.